InsidersTradesSigma
Track the NovoCure Limited share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). The latest transaction was filed on 23 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: NICOLAS LEUPIN. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
NovoCure Limited is a biotechnology company that develops treatments for cancer patients. It is listed on the NASDAQ under the symbol NVCR.